Mandatory fasting for 8 hours. Pre-operative assessment including EKG, blood panel, and pulmonary function tests. Implementation of VTE prophylaxis, patient education on diet, and psychological clearance.
Post-operative monitoring for 24-48 hours including pain management, early mobilization, and progressive clear liquid diet. Transition to soft food diets, vitamin supplementation, and regular follow-up for monitoring weight loss and potential complications.
Laparoscopic Sleeve Gastrectomy: A Comprehensive Clinical Guide
Laparoscopic Sleeve Gastrectomy (LSG) has ascended to become the most frequently performed bariatric procedure globally. As a restrictive metabolic surgery, it involves the surgical removal of approximately 75–80% of the stomach, leaving behind a slender, banana-shaped gastric tube. This guide serves as an authoritative clinical resource for medical professionals and informed patients regarding the technical, physiological, and clinical landscape of LSG.
1. Introduction and Clinical Overview
Laparoscopic Sleeve Gastrectomy (LSG) is a restrictive bariatric procedure that induces weight loss primarily by limiting gastric volume and altering gut-brain hormonal signaling. Unlike the Roux-en-Y Gastric Bypass (RYGB), LSG does not involve intestinal rerouting (malabsorption), making it technically less complex but physiologically profound in its metabolic impact.
The procedure is performed via minimally invasive laparoscopic techniques, utilizing several small abdominal incisions. By removing the gastric fundus and body along the greater curvature, the surgeon excise the primary site of ghrelin production (the "hunger hormone"), which significantly reduces post-operative appetite and cravings.
2. Technical Specifications and Mechanism of Action
The mechanism of LSG is multifaceted, combining physical restriction with profound hormonal shifts.
The Surgical Technique
The procedure is standardized as follows:
1. Access: Creation of pneumoperitoneum and insertion of trocars.
2. Dissection: The greater curvature of the stomach is mobilized by dividing the short gastric vessels.
3. Calibration: A sizing bougie (typically 32–40 French) is inserted into the stomach to serve as a guide for the staple line.
4. Resection: Using linear surgical staplers, the stomach is transected starting 2–6 cm from the pylorus and extending up to the angle of His.
5. Assessment: The staple line is inspected for hemostasis and integrity, often via an intraoperative leak test (e.g., methylene blue or air insufflation).
Physiological Mechanisms
- Restrictive Component: The gastric capacity is reduced from ~1.5 liters to ~100–150 mL.
- Hormonal Component: Removal of the fundus results in a precipitous drop in plasma ghrelin levels.
- Gastric Emptying: The removal of the antral "pump" and the creation of a high-pressure system accelerate gastric emptying, which increases the delivery of nutrients to the distal ileum, stimulating GLP-1 and PYY (satiety hormones).
3. Clinical Indications and Patient Selection
Patient selection for LSG is governed by the NIH Consensus Development Conference guidelines, though these have evolved to include lower BMI thresholds for patients with metabolic comorbidities.
Indications for Surgery
| Patient Criteria | Requirement |
|---|---|
| BMI Threshold | ≥ 40 kg/m² or ≥ 35 kg/m² with comorbidities |
| Comorbidities | Type 2 Diabetes, Hypertension, OSA, NAFLD |
| Prior Attempts | Documented failure of structured diet/exercise programs |
| Psychological Status | Absence of active, untreated psychiatric instability |
Contraindications
- Absolute: Severe coagulopathy, portal hypertension with esophageal varices, untreated severe eating disorders.
- Relative: Severe gastroesophageal reflux disease (GERD) – LSG can exacerbate pre-existing reflux due to increased intragastric pressure.
4. Pre-operative Preparation Protocol
Success in bariatric surgery is heavily dependent on the "pre-hab" phase.
- Multidisciplinary Evaluation: Clearance from a registered dietitian, psychologist, and internist.
- Weight Loss Optimization: Many surgeons require a 5–10% total body weight loss prior to surgery to reduce liver volume and improve visualization.
- Nutritional Optimization: Baseline screening for deficiencies in Vitamin B12, Vitamin D, Iron, and Folate.
- Smoking Cessation: Mandatory cessation at least 6 weeks pre-op to prevent wound healing complications and staple line leaks.
5. Post-operative Recovery and Long-term Management
The Immediate Post-op Phase (0–4 weeks)
Patients follow a strict progression of dietary intake:
* Phase 1 (Days 1–7): Clear liquids only.
* Phase 2 (Weeks 2–4): Full liquids and pureed foods.
* Phase 3 (Weeks 4–8): Introduction of soft, protein-rich solids.
Long-term Nutritional Requirements
Because the stomach is significantly reduced, patients are at high risk for micronutrient deficiencies. Mandatory supplementation includes:
* Multivitamins: High-potency bariatric-specific formulations.
* Calcium Citrate: 1,200–1,500 mg daily.
* Vitamin B12: Sublingual or monthly injections.
* Protein: 60–80g of protein daily to prevent muscle wasting.
6. Risks, Potential Complications, and Management
While LSG is safe, it is a major surgical intervention with inherent risks.
Early Complications
- Staple Line Leak: The most feared complication. Occurs in 1–2% of cases. Symptoms include tachycardia, fever, and abdominal pain. Managed with drainage, antibiotics, or endoscopic stenting.
- Hemorrhage: Bleeding from the staple line or short gastric vessels.
- Venous Thromboembolism (VTE): Prevented via early ambulation and prophylactic anticoagulation.
Late Complications
- De Novo GERD: Observed in 20–30% of patients. Often requires long-term PPI therapy.
- Strictures: Narrowing of the sleeve, often at the incisura angularis.
- Weight Regain: Can occur due to "stretching" of the sleeve or behavioral recidivism.
7. Alternative Treatments
Patients who are not candidates for LSG or who seek different outcomes may consider:
- Roux-en-Y Gastric Bypass (RYGB): The "Gold Standard" for patients with severe, recalcitrant GERD or uncontrolled Type 2 Diabetes.
- Biliopancreatic Diversion with Duodenal Switch (BPD/DS): Reserved for patients with a BMI > 50 kg/m² or severe metabolic syndrome.
- Endoscopic Procedures: Intragastric balloons or endoscopic sleeve gastroplasty (ESG) for patients with lower BMIs (30–35 kg/m²).
8. Massive FAQ Section
Q1: How much weight will I lose after LSG?
A: Most patients lose 60–70% of their excess body weight within 12–18 months.
Q2: Will the stomach grow back?
A: The stomach can dilate if overfilled consistently over years, but it does not "grow back." Behavioral adherence is key.
Q3: Can I become pregnant after surgery?
A: Yes, but it is highly recommended to wait 18–24 months post-op to ensure nutritional stability for the fetus.
Q4: Is the procedure reversible?
A: No. Unlike the Gastric Band, the Sleeve Gastrectomy involves the permanent removal of stomach tissue.
Q5: Will I need to take vitamins for the rest of my life?
A: Yes. Because the surface area for nutrient absorption is altered and food intake is restricted, lifelong supplementation is mandatory.
Q6: What is the risk of a staple line leak?
A: The risk is low, generally reported between 0.5% and 2%. Advanced laparoscopic training and careful technique have significantly reduced this risk.
Q7: Will my diabetes be cured?
A: Many patients see complete remission of T2DM shortly after surgery, often before significant weight loss occurs, due to hormonal changes.
Q8: Can I drink carbonated beverages after surgery?
A: It is generally discouraged, as the carbonation can cause discomfort and potential stretching of the staple line.
Q9: How long is the hospital stay?
A: Most patients are discharged within 24–48 hours post-operation.
Q10: Is LSG covered by insurance?
A: Most insurance providers cover LSG if the patient meets the criteria defined by the American Society for Metabolic and Bariatric Surgery (ASMBS).
9. Conclusion
Laparoscopic Sleeve Gastrectomy represents a surgical milestone in the treatment of obesity and its related metabolic disorders. By balancing a relatively straightforward operative technique with significant hormonal and restrictive benefits, it remains the primary choice for millions of patients. However, the procedure is merely a tool; long-term success necessitates a permanent commitment to dietary discipline, regular exercise, and lifelong medical follow-up.
Clinicians must ensure that patients are fully informed of the risks, specifically regarding long-term GERD management and the necessity of strict nutritional adherence. As surgical technology advances, further refinements in staple line reinforcement and robotic-assisted techniques continue to enhance the safety profile and efficacy of this life-changing procedure.